Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FL103
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,499
Award facts
- Contract value 100% obligated
- $13,499.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13.5K to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units), with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. The award represents a task order execution under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Entresto is a combination heart failure medication used in military and veteran healthcare systems to reduce the risk of cardiovascular death and hospitalization. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains extensive contract relationships with the Defense Logistics Agency for the supply of diverse pharmaceutical products across multiple therapeutic domains. The company's federal contracting demonstrates consistent capability to meet government procurement requirements through full and open competition, delivering both brand-name and generic medications, vaccines, and medical supplies to support Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FL103?
SPE2DR26FL103 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FL103 worth?
The government has obligated $13,499 on SPE2DR26FL103.
Is contract SPE2DR26FL103 an order under another contract?
Yes. SPE2DR26FL103 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL103 competed?
The extent of competition for SPE2DR26FL103 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award